226
Participants
Start Date
July 15, 2020
Primary Completion Date
September 9, 2024
Study Completion Date
September 9, 2024
Bentracimab (PB2452) Infusion
"Bentracimab (PB2452) 18 g Intravenous Infusion over a 16 hour duration.~In subjects with potential drug interaction from recent concomitant use of moderate or strong CYP3A inhibitors with ticagrelor, the active treatment period may be 24 hours and 10 min if receiving the 36g infusion.~In patients presenting with intracranial hemorrhage (ICH), brain imaging within 2 hours of initiation of study drug and at least one follow-up brain imaging performed 12-24 hours post completion of PB2452."
Klinik Ottakring 3rd Med Dept, Cardiology and Intensive Care Medicine, Vienna
University Hospital Antwerp Cardiology Department - Clinical Trials, Edegem
Klinische Abteilung für Innere Medizin 3 Universitätsklinikum St. Pölten, Sankt Pölten
Jessa Hospital Hartcentrum Hasselt Research Center, Hasselt
Ziekenhuis Oost-Limburg Study Center Intensive Care, Genk
Universitatsspital Basel Department of Cardiology, Basel
Cardiocentro Ticino, Lugano
AZ Sint-Jan Brugge-Oostende AV Poli Cardiologie, Bruges
Medical University Of Graz, Graz
Algemeen Stedelijk Ziekenhuis (ASZ) Study Center Cardiology, Aalst
Complejo Hospitalario Universitario A Coruna, A Coruña
Istituto Clinico Humanitas UO Cardiologia Clinica e Interventistica, Rozzano
ASST Monza - Ospedale San Gerardo, Monza
Sinai Hospital of Baltimore, Baltimore
Skane University Hospital, Department of Cardiology, Lund
Hospital Universitario 12 de Octubre, Residencia general, Madrid
Hospital Universitario Vírgen de la Victoria, Málaga
University of Florida Health, Jacksonville, Jacksonville
CHRU de Tours - Hopital Trousseau Service de Cardiologie-USCI 2 eme etage, Tours
University of Kentucky, Lexington
Hospital Universitario Virgen Macarena, Seville
Azienda Ospedaliero-Universitaria di Parma Cardiologia, Parma
The First Affiliated Hospital of Zhengzhou University, Zhengzhou
Henry Ford Hospital, Detroit
Sanford Medical Center Fargo, Fargo
CHU de Lille Service USIC, Institut Coeur Poumon, Lille
North Kansas City Hospital, North Kansas City
Cox Medical Centers, Springfield
Klinikum der Stadt Ludwigshafen gGmbH, Ludwigshafen
Ascension St. John Clinical Research Institute, Tulsa
Assistance Publique-Hopitaux de Paris (AP-HP) Pitie-Salpetriere Hospital, Paris
Bichat Hospital, Service de Cardiologie, Paris
Beijing Anzhen Hospital, Capital Medical University, Beijing
Peking University First Hospital, Beijing
Peking University People's Hospital, Beijing
Peking University Third Hospital, Beijing
The First Hospital of Jilin University, Changchun
The Second Affiliated Hospital of Jilin University, Changchun
The First Affiliated Hospital of Harbin Medical University, Harbin
Shanghai General Hospital, Shanghai
First Affiliated Hospital of Soochow University, Suzhou
Huai'an First People's Hospital, Huai'an
Tianjin Medical University General Hospital, Tianjin
Tianjin Chest Hospital, Tianjin
Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou
Medidata, Hangzhou
The Second Affiliated Hospital of Nanchang University, Nanchang
The Central Hospital of Wuhan, Wuhan
Renmin Hospital of Wuhan University, Wuhan
Guizhou Provincial People's Hospital, Guiyang
Lanzhou University Second Hospital, Lanzhou
General Hospital of Ningxia Medical University, Yinchuan
Rhode Island Hospital, Providence
Foothills Medical Centre, Calgary
Saint John Regional Hospital, Saint John
William Osler Health System, Etobicoke
Hamilton Health Sciences Centre, Hamilton
Kingston Health Science Centre, Kingston
York PCI Group, Inc., Newmarket
St. Michael's Hospital, Unity Health Toronto, Toronto
Toronto General Hospital, Toronto
Montreal Heart Institute, Montreal
Medisch Spectrum Twente, Enschede
St Antonius Hospital, Nieuwegein
Hospital Universitario Vall d'Hebron, Barcelona
Sahlgrenska University Hospital, Gothenburg
East and North Hertfordshire, NHS Trust, Lister Cardiac Research Office, Cardiology Green Zone, Lister Hospital, Stevenage
Sheffield Teaching Hospitals, NHS Foundation Trust, Northern General Hospital, Sheffield
SFJ Pharmaceuticals, Inc.
INDUSTRY